Since loss of INK4A/ARF expression is one of the most common somatic events in human tumors and is associated with elevated TYMS levels [13, 19, 20], we reasoned that activated TYMS may cooperate with INK4a/ARF loss to promote tumor growth. The gene discussed is CDKN2A; the disease is neoplasm.